Active, not recruitingPhase 4NCT05044819

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Studying Lennox-Gastaut syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jazz Pharmaceuticals
Intervention
Cannabidiol(drug)
Enrollment
154 enrolled
Eligibility
1 years · All sexes
Timeline
2021 – 2027

Study locations (19)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05044819 on ClinicalTrials.gov

Other trials for Lennox-Gastaut syndrome

Additional recruiting or active studies for the same condition.

See all trials for Lennox-Gastaut syndrome →

← Back to all trials